SCHEMBL4121858

SCHEMBL4121858

NC1=NC=CC(N)(c2ccc3[nH]ncc3c2)N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.46
MAPT P10636 3/20 0.46
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46
ROCK1 Q13464 1/20 0.46
HIF1A Q16665 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NOS1 P29475 4/20 0.40
METAP2 P50579 1/20 0.40
CSNK2A1 P68400 1/20 0.40
CHEK1 O14757 1/20 0.38
GSK3B P49841 3/20 0.38
PIM1 P11309 2/20 0.38
AURKB Q96GD4 2/20 0.38
MAPKAPK2 P49137 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4277498 0.89 MAPT (0.46) ROCK2MAPTKDM4EMEN1KMT2A
SCHEMBL4121853 0.70 ROCK2 (0.46) ROCK2MAPTKDM4EMEN1KMT2A
SCHEMBL4292715 0.70 TAAR1 (0.32) MAPTALDH1A1GAATDP1CYP2D6
SCHEMBL4281846 0.70 DRD2 (0.33) KDM4ERAB9AMAOB
SCHEMBL2846014 0.70 BACE1 (0.37) ALDH1A1MAOB
SCHEMBL3990101 0.69 KDM4E (0.51) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL30611466 0.67 ROCK2 (0.39) ROCK2MAPTKDM4EMEN1KMT2A
SCHEMBL31158403 0.66 SLC6A2 (0.53) ROCK2MAPTKDM4EMEN1KMT2A
SCHEMBL26633622 0.66 SLC6A2 (0.53) ROCK2MAPTKDM4EMEN1KMT2A
SCHEMBL117208 0.65 ROCK2 (1.00) ROCK2MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009063240-A1 2,4-DIAMINOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF AURORA KINASE ARROW THERAPEUTICS LIMITED (GB) 2009-05-22 WO disclosed